GLIOSARCOMA
Clinical trials for GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new GLIOSARCOMA trials appear
Sign up with your email to follow new studies for GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental brain cancer drug shows promise in early trial
Disease control TerminatedThis early-stage trial tested the drug navtemadlin in 32 adults with glioblastoma, an aggressive brain cancer. The goal was to find the safest dose and see how much drug reaches the tumor. The study was stopped early, but results may guide future treatments.
Matched conditions: GLIOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
Hormone therapy explored for aggressive brain tumor
Disease control TerminatedThis early-phase trial tested whether natural progesterone, a hormone, could help control tumor growth in patients with recurrent glioblastoma (a type of brain cancer). Only 4 patients were enrolled before the study was stopped. The goal was to find the right dose and check for s…
Matched conditions: GLIOSARCOMA
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Experimental brain tumor combo shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called zotiraciclib (TG02) combined with the standard chemotherapy temozolomide in adults with recurrent anaplastic astrocytoma or glioblastoma. The goal was to find safe doses and see if the combination works better than temozolomide alone.…
Matched conditions: GLIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC